tiprankstipranks
Parenteral Drugs (India) Limited (IN:PDPL)
:PDPL
India Market
PDPL
Parenteral Drugs (India) Limited
RESEARCH TOOLSreports
Want to see IN:PDPL full AI Analyst Report?

Parenteral Drugs (India) Limited (PDPL) Financial Statements

0 Followers

Parenteral Drugs (India) Limited Financial Overview

Parenteral Drugs (India) Limited's market cap is currently ₹101.08M. The company's EPS TTM is $-3.28; its P/E ratio is ―; Parenteral Drugs (India) Limited is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Mar 21Mar 20Mar 19Mar 18
Income Statement
Total Revenue₹ 84.96M₹ 121.53M₹ 240.25M₹ 319.98M₹ 2.17B
Gross Profit₹ 30.31M₹ 48.37M₹ 13.40M₹ 75.64M₹ 370.93M
Operating Income₹ -117.56K₹ -82.97K₹ -320.32K₹ -867.78K₹ -425.13M
EBITDA₹ 372.69M₹ -117.09M₹ -144.39M₹ -162.40M₹ -12.93M
Net Income₹ -763.62M₹ -1.22B₹ -1.14B₹ -1.48B₹ -1.19B
Balance Sheet
Cash & Short-Term Investments₹ 1.00K₹ 569.89K₹ 1.08M₹ 953.02K₹ 764.25K
Total Assets₹ 4.84B₹ 5.68B₹ 5.52B₹ 5.41B₹ 8.90B
Total Debt₹ 1.07B₹ 10.72B₹ 9.46B₹ 8.40B₹ 8.25B
Net Debt₹ 1.07B₹ 10.72B₹ 9.46B₹ 8.40B₹ 8.24B
Total Liabilities₹ 13.08B₹ 12.51B₹ 11.13B₹ 9.87B₹ 10.27B
Stockholders' Equity₹ -8.24B₹ -6.83B₹ -5.61B₹ -4.47B₹ -1.36B
Cash Flow
Free Cash Flow₹ -4.83M₹ 1.25B₹ 1.12B₹ 4.77B₹ 1.66B
Operating Cash Flow₹ -4.83M₹ 1.25B₹ 1.12B₹ 4.77B₹ 1.67B
Investing Cash Flow₹ 647.25M₹ 618.56K₹ 789.25K₹ 965.77M₹ -6.18M
Financing Cash Flow₹ -642.99M₹ -1.25B₹ -1.12B₹ -5.74B₹ -1.67B
Currency in INR

Parenteral Drugs (India) Limited Earnings and Revenue History

Income Statement >

Parenteral Drugs (India) Limited Debt to Assets

Balance Sheet >

Parenteral Drugs (India) Limited Cash Flow

Cash Flow >

Parenteral Drugs (India) Limited Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >